Exercise Program to Improve Life Quality After Myeloma Treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests whether a 6-month personalized exercise program—done partly at home and partly at a center—can improve quality of life for patients with multiple myeloma (a blood cancer) who are receiving ongoing chemotherapy or targeted drugs. The program is tailored to your abilities and fits into your regular hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Recently diagnosed with multiple myeloma or experiencing a relapse (cancer returning), and over 60 years old
- Started a new line of treatment within the last 3 months (your 1st, 2nd, 3rd, or 4th treatment plan)
- Receiving ongoing systemic treatment (chemotherapy or drugs) with hospital visits at least twice monthly for the first 3 months, then at least once monthly after that
- Able to speak and understand French
- No severe heart problems related to amyloidosis (abnormal protein buildup)
- Cleared by your doctor to safely do physical activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lifestyle program that includes physical activity and nutrition guidance for people who have had multiple myeloma for at least a year. The goal is to see if this program helps improve quality of life and overall well-being.
This study tests a strength training program for people with multiple myeloma who are on treatment. It aims to see if regular resistance exercise can help improve their physical condition and well-being.
This study looks at whether simple, guided breathing exercises can improve heart and lung health in people with multiple myeloma. It may help you feel stronger and manage side effects during treatment.
This study compares quality of life and treatment results in people with relapsed or refractory multiple myeloma who receive either newer or standard immunotherapy. It aims to understand how these treatments affect daily living and outcomes.
This study looks at how multiple myeloma and its treatment affect the daily life, well-being, and social activities of patients and their caregivers. It aims to understand what factors influence their quality of life.
This trial tests whether a prehabilitation program using adapted physical activity can help multiple myeloma patients prepare for a stem cell transplant. It may improve your strength and recovery before and after the transplant.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.